ATRX and central nervous system cancer: In subgroup overall survival analyses based on well-established molecular markers of glioma (i.e., IDH, p53, Ki-67, ATRX), IDH wildtype and high Ki67 expression emerged as a significant predictor across all subgroups irrespective of autophagy markers.